Global DTaP and Tdap Vaccines Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 DTaP and Tdap Vaccines Market Overview

1.1 DTaP and Tdap Vaccines Definition

1.2 Global DTaP and Tdap Vaccines Market Size Status and Outlook (2019-2032)

1.3 Global DTaP and Tdap Vaccines Market Size Comparison by Region (2019-2032)

1.4 Global DTaP and Tdap Vaccines Market Size Comparison by Type (2019-2032)

1.5 Global DTaP and Tdap Vaccines Market Size Comparison by Application (2019-2032)

1.6 Global DTaP and Tdap Vaccines Market Size Comparison by Sales Channel (2019-2032)

1.7 DTaP and Tdap Vaccines Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global DTaP and Tdap Vaccines Market Snapshot

2.2 Global DTaP and Tdap Vaccines Market Volume & Revenue (2019-2025)

2.3 Global DTaP and Tdap Vaccines Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global DTaP and Tdap Vaccines Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global DTaP and Tdap Vaccines Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global DTaP and Tdap Vaccines Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 DTaP and Tdap Vaccines Market Segment Analysis by Player

3.1 Global DTaP and Tdap Vaccines Sales and Market Share by Player (2023-2025)

3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Player (2023-2025)

3.3 Global DTaP and Tdap Vaccines Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 DTaP and Tdap Vaccines Market Segment Analysis by Type

4.1 Global DTaP and Tdap Vaccines Market by Type

4.1.1 DTaP

4.1.2 Td

4.1.3 Tdap

4.2 Global DTaP and Tdap Vaccines Sales and Market Share by Type (2019-2025)

4.3 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2019-2025)

4.4 Global DTaP and Tdap Vaccines Average Price by Type (2019-2025)

4.5 Leading Players of DTaP and Tdap Vaccines by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 DTaP and Tdap Vaccines Market Segment Analysis by Application

5.1 Global DTaP and Tdap Vaccines Market by Application

5.1.1 Adult

5.1.2 Pediatric

5.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of DTaP and Tdap Vaccines by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 DTaP and Tdap Vaccines Market Segment Analysis by Sales Channel

6.1 Global DTaP and Tdap Vaccines Market by Sales Channel

6.1.1 Global DTaP and Tdap Vaccines Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global DTaP and Tdap Vaccines Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of DTaP and Tdap Vaccines by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 DTaP and Tdap Vaccines Market Segment Analysis by Region

7.1 Global DTaP and Tdap Vaccines Market Size and CAGR by Region (2019-2032)

7.2 Global DTaP and Tdap Vaccines Sales and Market Share by Region (2019-2025)

7.3 Global DTaP and Tdap Vaccines Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America DTaP and Tdap Vaccines Market Share by Type

7.4.3 North America DTaP and Tdap Vaccines Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe DTaP and Tdap Vaccines Market Share by Type

7.5.3 Europe DTaP and Tdap Vaccines Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific DTaP and Tdap Vaccines Market Share by Type

7.6.3 Asia-Pacific DTaP and Tdap Vaccines Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America DTaP and Tdap Vaccines Market Share by Type

7.7.3 South America DTaP and Tdap Vaccines Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa DTaP and Tdap Vaccines Market Share by Type

7.8.3 Middle East & Africa DTaP and Tdap Vaccines Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading DTaP and Tdap Vaccines Players

8.1 Sanofi Pasteur

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 GlaxoSmithKline

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Protein Sciences Corporation

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Novartis AG

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Seqirus

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Merck Sharp & Dohme Corp

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Astellas Pharma US Inc

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Pfizer Inc

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Johnson & Johnson

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Lanzhou Institute of Biological Products Co. Ltd

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 AstraZeneca

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Emergent BioSolutions Inc

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Others

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of DTaP and Tdap Vaccines

9.1 Industrial Chain of DTaP and Tdap Vaccines

9.2 Upstream of DTaP and Tdap Vaccines

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of DTaP and Tdap Vaccines

9.3.1 Leading Distributors/Dealers of DTaP and Tdap Vaccines

9.3.2 Leading Consumers of DTaP and Tdap Vaccines

Chapter 10. Global DTaP and Tdap Vaccines Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global DTaP and Tdap Vaccines Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. DTaP and Tdap Vaccines Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of DTaP and Tdap Vaccines (2026-2032)

11.1 Global DTaP and Tdap Vaccines Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global DTaP and Tdap Vaccines Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global DTaP and Tdap Vaccines Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global DTaP and Tdap Vaccines Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global DTaP and Tdap Vaccines Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America DTaP and Tdap Vaccines Import-Export (2019-2025)

12.2 Europe DTaP and Tdap Vaccines Import-Export (2019-2025)

12.3 Asia Pacific DTaP and Tdap Vaccines Import-Export (2019-2025)

12.4 South America DTaP and Tdap Vaccines Import-Export (2019-2025)

12.5 Middle East & Africa DTaP and Tdap Vaccines Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America DTaP and Tdap Vaccines Demand-Supply (2019-2025)

13.2 Europe DTaP and Tdap Vaccines Demand-Supply (2019-2025)

13.3 Asia Pacific DTaP and Tdap Vaccines Demand-Supply (2019-2025)

13.4 South America DTaP and Tdap Vaccines Demand-Supply (2019-2025)

13.5 Middle East & Africa DTaP and Tdap Vaccines Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources